Compression of Morbidity Is Observed Across Cohorts with Exceptional Longevity

Khadija Ismail, Lisa Nussbaum, Paola Sebastiani, Stacy Andersen, Thomas Perls, Nir Barzilai, Sofiya Milman

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Objectives: To determine, in a sample of Ashkenazi Jewish aged 95 and older, whether there is a compression of morbidity similar to what has been reported in other cohorts with exceptional longevity. Design: Case–control study. Setting: Longevity Genes Project (LGP) and New England Centenarian Study (NECS). Participants: LGP (n = 439, mean age 97.8 ± 2.8) and NECS (n = 1,498, mean age 101.4 ± 4.0) participants with exceptional longevity and their respective younger referent cohorts (LGP, n = 696; NECS, n = 302). Measurements: Self- and proxy reports of age of onset of cancer, cardiovascular disease, diabetes mellitus, hypertension, osteoporosis, and stroke. Results: Long-lived individuals from LGP and NECS had later age of onset of cancer, cardiovascular disease, diabetes mellitus, hypertension, and osteoporosis than their respective younger reference groups. The risk of overall morbidity was lower in participants with exceptional longevity than in younger participants (NECS men: relative risk (RR) = 0.12, women: RR = 0.20; LGP men: RR = 0.18, women: RR = 0.24). The age at which 20% of each of the groups with exceptional longevity experienced specific diseases was between 18 and 24 years later than in the reference groups, stratified according to sex. Conclusion: The similar extension of health span and compression of morbidity seen in NECS and LGP participants with exceptional longevity further validates the utility of these rare individuals for the study of factors that delay or prevent a broad spectrum of diseases otherwise associated with mortality and disability.

Original languageEnglish (US)
Pages (from-to)1583-1591
Number of pages9
JournalJournal of the American Geriatrics Society
Volume64
Issue number8
DOIs
StatePublished - Aug 1 2016

Fingerprint

Morbidity
New England
Genes
Age of Onset
Osteoporosis
Diabetes Mellitus
Cardiovascular Diseases
Hypertension
Proxy
Self Report
Neoplasms
Stroke
Mortality
Health

Keywords

  • compression of morbidity
  • health span
  • longevity
  • older adults

ASJC Scopus subject areas

  • Medicine(all)
  • Geriatrics and Gerontology

Cite this

Compression of Morbidity Is Observed Across Cohorts with Exceptional Longevity. / Ismail, Khadija; Nussbaum, Lisa; Sebastiani, Paola; Andersen, Stacy; Perls, Thomas; Barzilai, Nir; Milman, Sofiya.

In: Journal of the American Geriatrics Society, Vol. 64, No. 8, 01.08.2016, p. 1583-1591.

Research output: Contribution to journalArticle

Ismail, Khadija ; Nussbaum, Lisa ; Sebastiani, Paola ; Andersen, Stacy ; Perls, Thomas ; Barzilai, Nir ; Milman, Sofiya. / Compression of Morbidity Is Observed Across Cohorts with Exceptional Longevity. In: Journal of the American Geriatrics Society. 2016 ; Vol. 64, No. 8. pp. 1583-1591.
@article{cbd81c108d47452bb5296c4d694a9528,
title = "Compression of Morbidity Is Observed Across Cohorts with Exceptional Longevity",
abstract = "Objectives: To determine, in a sample of Ashkenazi Jewish aged 95 and older, whether there is a compression of morbidity similar to what has been reported in other cohorts with exceptional longevity. Design: Case–control study. Setting: Longevity Genes Project (LGP) and New England Centenarian Study (NECS). Participants: LGP (n = 439, mean age 97.8 ± 2.8) and NECS (n = 1,498, mean age 101.4 ± 4.0) participants with exceptional longevity and their respective younger referent cohorts (LGP, n = 696; NECS, n = 302). Measurements: Self- and proxy reports of age of onset of cancer, cardiovascular disease, diabetes mellitus, hypertension, osteoporosis, and stroke. Results: Long-lived individuals from LGP and NECS had later age of onset of cancer, cardiovascular disease, diabetes mellitus, hypertension, and osteoporosis than their respective younger reference groups. The risk of overall morbidity was lower in participants with exceptional longevity than in younger participants (NECS men: relative risk (RR) = 0.12, women: RR = 0.20; LGP men: RR = 0.18, women: RR = 0.24). The age at which 20{\%} of each of the groups with exceptional longevity experienced specific diseases was between 18 and 24 years later than in the reference groups, stratified according to sex. Conclusion: The similar extension of health span and compression of morbidity seen in NECS and LGP participants with exceptional longevity further validates the utility of these rare individuals for the study of factors that delay or prevent a broad spectrum of diseases otherwise associated with mortality and disability.",
keywords = "compression of morbidity, health span, longevity, older adults",
author = "Khadija Ismail and Lisa Nussbaum and Paola Sebastiani and Stacy Andersen and Thomas Perls and Nir Barzilai and Sofiya Milman",
year = "2016",
month = "8",
day = "1",
doi = "10.1111/jgs.14222",
language = "English (US)",
volume = "64",
pages = "1583--1591",
journal = "Journal of the American Geriatrics Society",
issn = "0002-8614",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Compression of Morbidity Is Observed Across Cohorts with Exceptional Longevity

AU - Ismail, Khadija

AU - Nussbaum, Lisa

AU - Sebastiani, Paola

AU - Andersen, Stacy

AU - Perls, Thomas

AU - Barzilai, Nir

AU - Milman, Sofiya

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Objectives: To determine, in a sample of Ashkenazi Jewish aged 95 and older, whether there is a compression of morbidity similar to what has been reported in other cohorts with exceptional longevity. Design: Case–control study. Setting: Longevity Genes Project (LGP) and New England Centenarian Study (NECS). Participants: LGP (n = 439, mean age 97.8 ± 2.8) and NECS (n = 1,498, mean age 101.4 ± 4.0) participants with exceptional longevity and their respective younger referent cohorts (LGP, n = 696; NECS, n = 302). Measurements: Self- and proxy reports of age of onset of cancer, cardiovascular disease, diabetes mellitus, hypertension, osteoporosis, and stroke. Results: Long-lived individuals from LGP and NECS had later age of onset of cancer, cardiovascular disease, diabetes mellitus, hypertension, and osteoporosis than their respective younger reference groups. The risk of overall morbidity was lower in participants with exceptional longevity than in younger participants (NECS men: relative risk (RR) = 0.12, women: RR = 0.20; LGP men: RR = 0.18, women: RR = 0.24). The age at which 20% of each of the groups with exceptional longevity experienced specific diseases was between 18 and 24 years later than in the reference groups, stratified according to sex. Conclusion: The similar extension of health span and compression of morbidity seen in NECS and LGP participants with exceptional longevity further validates the utility of these rare individuals for the study of factors that delay or prevent a broad spectrum of diseases otherwise associated with mortality and disability.

AB - Objectives: To determine, in a sample of Ashkenazi Jewish aged 95 and older, whether there is a compression of morbidity similar to what has been reported in other cohorts with exceptional longevity. Design: Case–control study. Setting: Longevity Genes Project (LGP) and New England Centenarian Study (NECS). Participants: LGP (n = 439, mean age 97.8 ± 2.8) and NECS (n = 1,498, mean age 101.4 ± 4.0) participants with exceptional longevity and their respective younger referent cohorts (LGP, n = 696; NECS, n = 302). Measurements: Self- and proxy reports of age of onset of cancer, cardiovascular disease, diabetes mellitus, hypertension, osteoporosis, and stroke. Results: Long-lived individuals from LGP and NECS had later age of onset of cancer, cardiovascular disease, diabetes mellitus, hypertension, and osteoporosis than their respective younger reference groups. The risk of overall morbidity was lower in participants with exceptional longevity than in younger participants (NECS men: relative risk (RR) = 0.12, women: RR = 0.20; LGP men: RR = 0.18, women: RR = 0.24). The age at which 20% of each of the groups with exceptional longevity experienced specific diseases was between 18 and 24 years later than in the reference groups, stratified according to sex. Conclusion: The similar extension of health span and compression of morbidity seen in NECS and LGP participants with exceptional longevity further validates the utility of these rare individuals for the study of factors that delay or prevent a broad spectrum of diseases otherwise associated with mortality and disability.

KW - compression of morbidity

KW - health span

KW - longevity

KW - older adults

UR - http://www.scopus.com/inward/record.url?scp=84982311253&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84982311253&partnerID=8YFLogxK

U2 - 10.1111/jgs.14222

DO - 10.1111/jgs.14222

M3 - Article

VL - 64

SP - 1583

EP - 1591

JO - Journal of the American Geriatrics Society

JF - Journal of the American Geriatrics Society

SN - 0002-8614

IS - 8

ER -